Publication | Closed Access

Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study

MedicineImmunologyPathologyBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyLung CancerSequential Therapy